ShangBay Capital is a leading venture capital firm based in the heart of innovation. We bring our investors access to best-in-class investments within the medical device, biotechnology, and healthcare technology sectors through early-stage venture equity participation.
ShangBay Capital continues to build new relationships with best-in-class investors, entrepreneurs, KOLs, strategics, and innovators of the industry. Our investments cover founders who have built disruptive companies that address high, unmet clinical needs with novel ideas.
With a combined 100+ years of experience, our strong leadership team has fostered deep ties to strategics and experienced innovators in disruptive technologies. Through leveraging our diverse expertise, we help founders satisfy large market needs and generate favorable returns.